| Title | Targeting sialylation enhances the therapeutic efficacy of Enfortumab Vedotin in bladder cancer (RNA-seq) |
|---|---|
| Description | RNA-seq of RT-112 and KU-19-19 cells |
| Organism | Homo sapiens |
| Data Type | Expression Profiling |
| Data Accessibility | Open-access |
| BioProject | PRJCA040153 |
| Release Date | 2025-09-22 |
| Submitter | Tao Xu (xutao@pkuph.edu.cn) |
| Organization | Peking University People's Hospital |
| Submission Date | 2025-09-01 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX011685-01 | 1 | 1 | Expression Profiling | 333.8 KB | zip |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer | Cancer Research | 2025-10 | OMIX011685 OMIX011667 | Deposit |